|
Abstract: . . . testinal pH measurement using 2=,7=- bis (carboxyethyl)5,6-carboxyfluo- rescein (BCECF) fluorescence imaging. Photochem Photobiol 1999; 70:813819. 19. Ntziachristos V, Bremer C, Graves EE, Ripoll J, Weissleder R. In vivo tomographic imaging of near-infrared fluorescent probes. Mol Imaging 2002; 1:8288. 20. Mansfield JR, Gossage KW, Hoyt CC, Levenson RM. Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. J Biomed Opt 2005; 10:19. . . . . . . Near-Infrared Characterization of Disease via Vascular Permeability Probes 1 Brian W. Pogue, PhD Diagnostic tools to noninvasively measure tissue function are still relatively limited, and the development of new contrast agents that . . . . . . arthritis rat model: A preliminary study. Pharm Res 2004; 21:17411749. 11. Sharp PF, Manivannan A. The scanning laser ophthalmoscope. Phys Med Biol 1997; 42:951966. 12. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in cho- riorefinal diseases : indications and interpretationan evidence-based update. Ophthalmology 2003; 110:1521. 13. Boucher Y, Brekken C, Netti PA, Baxter LT, Jain RK. Intratumoral infu- sion of fluid: estimation of hydraulic conductivity and implications for the . . . . . . Near-Infrared Characterization of Disease via Vascular Permeability Probes 1 Brian W. Pogue, PhD Diagnostic tools to noninvasively measure tissue function are still relatively limited, and the development of new contrast agents that will provide information about . . . . . . Rajadhyaksha M, Momma T, Soukos NS, Hasan T. In vivo fluorescence imaging of the transport of charged chlorin e6 conju- gates in a rat orthotopic prostate tumour. Br J Cancer 1999; 81:261 268. 9. Dellian M, Yuan F, Trubetskoy VS, Torchilin VP, Jain RK. Vascular per- meability in a human tumour xenograft: molecular charge dependence. Br J Cancer 2000; 82:15131518. 10. Wang D, Miller SC, Sima M, et al. The arthrotropism of macromole- cules in adjuvant-induced arthritis rat model: A preliminary study. . . . --2671,5,267,2601,13354
|